catechin has been researched along with Choroid Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Du, S; Gu, Y; Guo, Y; Song, E; Sun, X; Tu, Y; Wang, Y; Xie, L; Xu, J; Xu, X; Zhao, Q; Zhu, M | 1 |
1 other study(ies) available for catechin and Choroid Neovascularization
| Article | Year |
|---|---|
Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization.
Topics: Animals; Catechin; Cell Polarity; Cells, Cultured; Choroidal Neovascularization; Down-Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Macular Degeneration; Male; Mice; Mice, Inbred C57BL; Microglia; Prodrugs; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2020 |